Lenegre disease, also known as progressive cardiac conduction defect (PCCD), is described as an alteration in the cardiac conduction network [1] [2]. It is believed that this disease is caused by a mutation in the SCN5A gene in combination with age-related degeneration and fibrosis of the His-Purkinje system and its branches [3] [4]. An electrocardiogram (EKG) performed in affected individuals will reveal a conduction delay in the His-Purkinje tissues and varying degrees of arterioventricular (AV) block and differing types of branch block [5] [6]. The cardiac structure and function are typically normal in these patients.

Lenegre disease is considered as one of the most predominant conductive disturbances and is a common cause of pacemaker implantation worldwide. Moreover, it is diagnosed in patients below the age of 50 who have unexplained conduction disease but normal heart structure and likely a family history positive for Lenegre disease [7].

While some patients exhibit no symptoms, others experience dyspnea, lightheadedness, dizziness, abdominal pain, and syncope. As a result of complete AV heart block, complications such as left ventricular dilatation, heart failure, and sudden cardiac death may ensue. The latter commonly occurs in advanced cases of first-degree AV block accompanied by a bi- fascicular block as well as patients with symptomatic AV block. However, pacemaker implantation improves the prognosis significantly.

Patients with the symptoms described above (such as syncope) or incidental EKG findings suggestive of a cardiac conductive defect warrant a thorough evaluation. In addition to ascertaining the personal history, the workup should include a detailed family history of diseases and manifestations such as syncope or sudden death. Patients should also undergo a complete physical exam with a focus on the cardiovascular system. Finally, affected individuals should be assessed with specific studies like electrocardiogram, echocardiogram etc.

Electrocardiogram (EKG)

Findings associated with Lenegre disease include prolonged PR interval, wide QRS complexes, right and/or left bundle branch block, as well as disturbances in other conductive tissues. An exercise stress test in patients with a complete AV block may reveal arrhythmias such as ventricular tachycardia and Torsade de Pointes.

Imaging

An echocardiogram and/or cardiac magnetic resonance imaging (MRI) are performed to assess the contractile function and structure of the heart and to rule out underlying abnormalities such as cardiomyopathy and congenital heart disease [7].

Other

Genetic testing is advised in young individuals with Lenegre disease.

The primary treatment for Lenegre Disease is the implantation of a pacemaker. A pacemaker is a small device placed under the skin that helps regulate the heart's rhythm by sending electrical impulses to prompt the heart to beat at a normal rate. This intervention is particularly important for patients experiencing significant symptoms or those at risk of severe heart block. In some cases, medications may be prescribed to manage symptoms or associated conditions, but they do not address the underlying conduction defect.

The prognosis for individuals with Lenegre Disease varies depending on the severity of the conduction defect and the timeliness of treatment. With appropriate management, particularly the use of a pacemaker, many patients can lead normal, active lives. However, without treatment, the condition can progress to complete heart block, which can be life-threatening. Regular follow-up with a cardiologist is essential to monitor the condition and adjust treatment as needed.

The exact cause of Lenegre Disease is not well understood, but it is believed to be related to degenerative changes in the heart's conduction system. These changes may be due to age-related wear and tear or genetic factors. In some cases, Lenegre Disease may be inherited, suggesting a possible genetic component. However, more research is needed to fully understand the underlying causes.

Lenegre Disease is considered a rare condition, with most cases occurring in older adults. It is more common in men than women and typically presents in individuals over the age of 50. The prevalence of the disease is not well-documented, but it is thought to be underdiagnosed due to its gradual onset and nonspecific symptoms.

The pathophysiology of Lenegre Disease involves the progressive fibrosis and sclerosis of the His-Purkinje system. This system is responsible for conducting electrical impulses from the atria to the ventricles, ensuring coordinated heartbeats. As fibrosis progresses, the conduction pathways become blocked or disrupted, leading to heart block and the associated symptoms. The exact mechanisms driving this fibrotic process are not fully understood but may involve genetic predispositions and age-related changes.

Currently, there are no specific measures to prevent Lenegre Disease, primarily due to its unclear etiology. However, maintaining overall cardiovascular health through a balanced diet, regular exercise, and avoiding smoking may help reduce the risk of developing heart-related conditions. Regular check-ups with a healthcare provider can also aid in early detection and management of any heart rhythm abnormalities.

Lenegre Disease is a rare cardiac condition characterized by the progressive deterioration of the heart's electrical conduction system, leading to heart block. It primarily affects older adults and can cause symptoms like dizziness, fatigue, and fainting. Diagnosis involves ECG and other cardiac tests, while treatment typically requires a pacemaker to regulate heart rhythm. Although the exact cause is unknown, genetic factors and age-related changes are believed to play a role. With proper management, patients can maintain a good quality of life.

If you or a loved one has been diagnosed with Lenegre Disease, it's important to understand that this condition affects the heart's ability to maintain a regular rhythm. Symptoms like dizziness and fainting occur because the heart isn't pumping blood effectively. A pacemaker is often used to help regulate the heartbeat and improve symptoms. Regular follow-ups with your doctor are crucial to ensure the condition is managed effectively. While the disease is rare, understanding your treatment options and maintaining a healthy lifestyle can help you live well with this condition.

1. Lev M, Kinare SG, Pick A. The pathogenesis of atrioventricular block in coronary disease. Circulation. 1970;42(3):409-25.
2. Lev M, Cuadros H, Milton HP. Interruption of the atrioventricular bundle with congenital atrioventricular block. Circulation. 1971;43(5):703-10.
3. Probst V, Kyndt F, Potet F, Trochu JN, Mialet G, Demolombe S, Schott JJ, Baró I, Escande D, Le Marec H. Haploinsufficiency in combination with aging causes SCN5A-linked hereditary Lenegre disease. J Am Coll Cardiol. 2003; 41(4):643–652.
4. Schott JJ, Alshinawi C, Kyndt F, et al. Cardiac conduction defects associate with mutations in SCN5A. Nat Genet. 1999; 23(1):20–21.
5. Baruteau AE, Probst V, Abriel H. Inherited progressive cardiac conduction disorders. Curr Opin Cardiol. 2015;30(1):33-9.
6. Lev M. The pathology of complete atrioventricular block. Prog Cardiovasc Dis. 1964;6:317-26.
7. Bharati S, Lev M, Dhingra RC, et al. Electrophysiological and pathological correlations in two cases of chronic second degree atrioventricular block with left bundle branch block. Circulation. 1975;52(2):221-9.